Emerging role of S-1 in gastric cancer

Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology
Eriseld KrasniqiVincenzo Formica

Abstract

Gastric cancer remains one of the most important malignancies worldwide in terms of incidence and mortality. The treatment is based on the combination of local surgery and radiation therapy as well as systemic chemotherapy and targeted molecules. Fluoropyrimidines and particularly 5-fluorouracil (FU) represent still the backbone for gastric cancer chemotherapy and new molecular versions of this molecule have been brought to clinical practice in order to improve benefits and reduce adverse effects. S-1 is an oral prodrug of 5-FU, which has demonstrated high effectiveness for gastric cancer treatment and a favorable safety profile. Currently, there are geographic differences in the treatment of gastric cancer and in the use of S-1, which is a mainstay of gastric cancer management in Eastern countries, but is not part of the standard care in the rest of the world. In this review, we gathered data from phase I, II, and III trials of S-1 in gastric cancer, in order to define its real benefit-risk ratio and assess whether geographic differences in S-1 use are justified by unchangeable factors.

References

Aug 1, 1988·American Journal of Clinical Oncology·T MoynihanM Vukelich
Dec 1, 1980·Japanese Journal of Pharmacology·I MatsubaraS Imai
Jan 20, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Y SakataT Taguchi
Nov 6, 2002·Annals of Surgical Oncology·Franco RovielloUNKNOWN Italian Research Group for Gastric Cancer
Jun 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Atsushi NashimotoUNKNOWN Gastric Cancer Surgical Study Group, Japan Clinical Oncology Group
Mar 30, 1957·Nature·C HEIDELBERGERJ SCHEINER
Mar 19, 2004·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·M DegiuliUNKNOWN Italian Gastric Cancer Study Group
Jun 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Godefridus J PetersJan H M Schellens
Aug 7, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Quincy Siu-Chung ChuEric K Rowinsky
Aug 21, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Y S HongJ Y Cho
Sep 8, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jaffer A AjaniPeter Urrea
Jul 11, 2006·The New England Journal of Medicine·David Cunningham MAGIC Trial Participants
Sep 26, 2006·Best Practice & Research. Clinical Gastroenterology·D Forman, V J Burley
Jan 4, 2008·The New England Journal of Medicine·David CunninghamUNKNOWN Upper Gastrointestinal Clinical Studies Group of the National Cancer Research Institute of the United Kingdom
Feb 27, 2009·Expert Opinion on Investigational Drugs·Muhammad Wasif SaifNikos A Katirtzoglou
Oct 13, 2009·The Lancet Oncology·Narikazu BokuUNKNOWN Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group
Feb 18, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jaffer A AjaniSilvia Falcon
Sep 3, 2010·Cancer Chemotherapy and Pharmacology·D TakahariM Sasako
Sep 22, 2010·World Journal of Gastroenterology : WJG·Ikuko MiyazakiFuminori Moriyasu
Dec 1, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrea DeCensi, Alessandra Gennari
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Feb 23, 2011·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Hiroyuki NaraharaYuh Sakata
Apr 5, 2011·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Toru AoyamaAkira Tsuburaya
Jul 12, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Peter C Thuss-PatiencePeter Reichardt
Jul 23, 2011·Oncology·Shigeyuki TamuraUNKNOWN Osaka Gastrointestinal Cancer Chemotherapy Study Group
Oct 14, 2011·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Kohei ShitaraAkira Tsuburaya
Oct 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mitsuru SasakoYasuo Ohashi
Nov 9, 2011·Journal of the Korean Surgical Society·Sung Ryol LeeChang Hak Yoo
Apr 25, 2012·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Toru AoyamaAkira Tsuburaya
May 16, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen R SmalleyJohn S Macdonald
May 31, 2013·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Daisuke TakahariMitsuru Sasako
Jun 6, 2013·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Kazumasa FujitaniHiroshi Furukawa

❮ Previous
Next ❯

Methods Mentioned

BETA
dissection
pancreatectomy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.